Physician profile
Ryan Walker
NPI 1457675589
$29,851.92
in general payments reported to CMS, 2019-2025
9 companies · $13K in 2025
The $13K reported for 2025 was more than what 98% of Pediatric Otolaryngology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $31.95 · 2021: $25.00 · 2022: $26.42 · 2023: $39.62 · 2024: $17K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Consulting Fee: $13K · Travel and Lodging: $2,738 · Food and Beverage: $1,922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,500.00 |
| Consulting Fee | $12,500.00 |
| Travel and Lodging | $2,737.51 |
| Food and Beverage | $1,922.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $29,289.50 | 2020-2025 | Coblation, Halo, Rapid Rhino |
| Inspire Medical Systems, INC. | $214.10 | 2025 | Inspire |
| Medtronic USA, INC. | $94.97 | 2019 | |
| Genzyme Corporation | $76.05 | 2021-2025 | |
| Optinose US, INC. | $50.72 | 2019-2024 | |
| Glaxosmithkline, LLC. | $44.64 | 2022-2024 | Nucala |
| Ars Pharmaceuticals Operations, INC. | $40.52 | 2025 | Neffy |
| Medtronic, INC. | $24.31 | 2023 | Ligasure |
| Alk-Abello, INC | $17.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.